Skip to main content
. 2024 Mar 5;16(5):741. doi: 10.3390/nu16050741
APC antigen-presenting cell
BDDCS biopharmaceutical drug disposition categorization system
CAT catalase
CFA Chronic Freund’s adjuvant
CIA collagen-induced arthritis
COX-1 cyclooxygenase-1
COX-2 cyclooxygenase-2
CRP c-reactive protein
DMARD disease-modifying antirheumatic drug
DMSO dimethyl sulfoxide
ECM extracellular matrix
ERK extracellular signal-regulated kinase
EULAR European League against Rheumatism
FLS fibroblast-like synoviocyte cells
FoxP3 forkhead box P3
GPX glutathione peroxidase
IκB-alfa nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
IFN-gamma interferon-gamma
IP-10 interferon-gamma-inducible protein 10 kD
JAK/STAT Janus kinase/signal transducers and activators of transcription
JNK c-Jun N-terminal kinase
MAPK mitogen-activated protein kinases
MCP-1 monocyte chemoattractant protein-1
MMP matrix metalloproteinase
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
NLC nanostructure lipid carrier
NSAIDs non-steroidal anti-inflammatory drugs
OA osteoarthritis
p38-MAPK p38 mitogen-activated protein kinases
PGE2 prostaglandin E2
PIK3/AKT phosphatidylinositol 3’-kinase-Akt signaling pathway
PPAR-γ peroxisome proliferator-activated receptor gamma
RA rheumatoid arthritis
RORγt RAR-related orphan receptor gamma
ROS reactive oxygen species
SCW streptococcal cell wall
SOD1 superoxide dismutase type 1
TGF transforming growth factor
TNF-α tumor necrosis factor
TRPV1 transient receptor potential vanilloid 1
VCAM-1 vascular cell adhesion molecule 1
VEGF vascular endothelial growth factor